Leadership Overview
Unilab has 8 executives leading key functions including strategy, finance, information technology, legal, and operations.
Driven by a commitment to health and wellness, Unilab manufactures pharmaceuticals and related products, impacting lives across the Philippines and beyond with its extensive portfolio.
Driven by a commitment to health and wellness, Unilab manufactures pharmaceuticals and related products, impacting lives across the Philippines and beyond with its extensive portfolio.
Leadership Roles at Unilab
Ralph Gray - Chief Executive Officer
Ralph Gray, the Chief Executive Officer at Unilab, directs the company's overall strategic vision and operational execution. Gray oversees all major business units, ensuring alignment with Unilab's mission to provide quality healthcare products. This leadership position involves driving innovation in pharmaceutical manufacturing and expanding market reach within the Philippines and international territories. Gray's focus includes optimizing resource allocation and fostering a culture of excellence across all departments. The Chief Executive Officer's responsibilities extend to stakeholder relations and long-term corporate planning, securing Unilab's sustained growth and market leadership. By guiding strategic initiatives, Ralph Gray ensures the company remains at the forefront of the pharmaceutical industry, addressing evolving healthcare needs with effective solutions.
Sebastian Baquiran - President & Chief Executive Officer
Sebastian Baquiran, the President & Chief Executive Officer at Unilab, spearheads the company's comprehensive strategic direction and operational management. Baquiran guides all facets of Unilab's business, ensuring adherence to its core mission of delivering accessible and high-quality pharmaceutical products. This executive role encompasses driving advancements in product development and enhancing distribution networks throughout the Philippines and key global markets. Baquiran's efforts concentrate on maximizing operational efficiencies and cultivating an environment of continuous improvement across all functional areas. The President & Chief Executive Officer's purview includes managing investor relations and shaping long-term corporate objectives, guaranteeing Unilab's ongoing expansion and prominent industry standing. Through directing critical business strategies, Sebastian Baquiran ensures the organization consistently meets and exceeds the dynamic demands of the healthcare sector.
Luis Vaca - Chief Financial Officer
Luis Vaca, the Chief Financial Officer at Unilab, manages the company's financial health and strategic fiscal planning. Vaca oversees all financial operations, including budgeting, forecasting, and capital management, ensuring Unilab's fiscal stability and growth. This role involves optimizing financial performance, managing investment strategies, and ensuring compliance with all regulatory financial standards across the Philippines and international markets. Vaca's responsibilities include driving cost-efficiency initiatives and identifying opportunities for financial optimization within the pharmaceutical manufacturing sector. The Chief Financial Officer's leadership supports strategic decision-making by providing critical financial insights and analysis. By meticulously managing financial resources, Luis Vaca directly contributes to Unilab's long-term sustainability and its capacity to invest in research and development for new pharmaceutical solutions.
Julio Cortes - President
Julio Cortes, the President at Unilab, drives the company's strategic growth and operational excellence. Cortes leads key business divisions, ensuring their alignment with Unilab's overarching mission to provide essential pharmaceutical products. This leadership role involves fostering innovation in product development and expanding market presence within the Philippines and globally. Cortes's efforts focus on enhancing operational efficiencies and cultivating a high-performance culture across all teams. The President's responsibilities include overseeing major strategic projects and ensuring the effective implementation of corporate objectives. By directing critical business functions, Julio Cortes significantly contributes to Unilab's sustained success and its ability to meet the evolving healthcare needs of diverse populations.
Manolet Montinola - Group President, Ul Health Services, Unilab
Manolet Montinola, the Group President, Ul Health Services, Unilab, leads the strategic direction and operational management of Unilab's health services division. Montinola oversees the expansion and integration of healthcare services, ensuring they complement Unilab's pharmaceutical offerings and enhance patient outcomes. This executive role involves driving innovation in healthcare delivery models and strengthening Unilab's position within the broader health ecosystem across the Philippines and beyond. Montinola's focus is on optimizing service delivery, fostering strategic partnerships, and ensuring the division meets its growth and impact objectives. The Group President's leadership is crucial for developing comprehensive healthcare solutions that address community needs. Through dedicated management of health services, Manolet Montinola reinforces Unilab's commitment to holistic well-being and accessible healthcare.
Francisco Ortega - Chief Information Officer
Francisco Ortega, the Chief Information Officer at Unilab, directs the company's technology strategy and digital transformation initiatives. Ortega oversees the development and implementation of IT infrastructure, ensuring robust cybersecurity measures and efficient data management across all Unilab operations. This position is critical for enhancing operational efficiency through advanced technological solutions, supporting the pharmaceutical manufacturing processes and distribution networks throughout the Philippines and beyond. Ortega's focus includes leveraging data analytics to drive business insights and improve decision-making. The Chief Information Officer's role ensures that Unilab's technological capabilities remain competitive and scalable, supporting innovation in product development and customer engagement. Through strategic technology leadership, Francisco Ortega empowers Unilab to adapt to the evolving digital landscape and maintain a strong competitive edge.
Jennifer Inocentes - Chief of Staff
Jennifer Inocentes, the Chief of Staff at Unilab, provides strategic support and operational coordination across executive functions. Inocentes facilitates the execution of key initiatives, ensuring seamless communication and alignment between departments and leadership. This role involves managing special projects, optimizing internal processes, and enhancing organizational effectiveness to support Unilab's mission in pharmaceutical manufacturing. Inocentes's responsibilities extend to driving cross-functional collaboration and ensuring timely progress on strategic priorities throughout the Philippines and international operations. The Chief of Staff's effectiveness is crucial for streamlining operations and enabling the executive team to focus on high-level strategic objectives. By orchestrating critical internal functions, Jennifer Inocentes significantly contributes to Unilab's operational agility and its ability to achieve its ambitious business goals.
Terence Lee - Chief Legal Officer
Terence Lee, the Chief Legal Officer at Unilab, oversees all legal affairs and ensures regulatory compliance for the company. Lee manages the legal framework governing Unilab's pharmaceutical manufacturing and distribution operations, safeguarding the company's interests across the Philippines and international markets. This position involves providing expert legal counsel on corporate governance, intellectual property, and contract negotiations. Lee's responsibilities include mitigating legal risks and ensuring adherence to all relevant industry regulations and ethical standards. The Chief Legal Officer plays a vital role in shaping corporate policy and advising the executive team on legal implications of business strategies. Through diligent legal oversight, Terence Lee supports Unilab's commitment to integrity and responsible business practices, ensuring sustained operational integrity.
Explore Leadership Teams in Manufacturing
AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.
Company Leadership

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
BB

RL
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS
RM
SC
Alvogen, founded in 2009 headquartered in Morristown, New Jersey, operates as a pharmaceutical company. The Company develops, manufactures, and markets parallel imported and generic drugs. Alvogen Pharma US serves clients worldwide.
Company Leadership SP
NB
JJ
JL